Nasdaq triple IPO play brings in $345M as the big biotech party rocks on

Nasdaq triple IPO play brings in $345M as the big biotech party rocks on

Source: 
Endpoints
snippet: 

After Entasis Therapeutics $ETTX hit the floor on Nasdaq Wednesday after pricing its offering below the range, the stock cratered fast, plunging 29% and likely causing a few frowns among the rest of the biotechs in the queue for an IPO. But overnight we saw three more drug developers go public, playing inside the range and raising a collective $345 million.